Aim: The identification of 7,8-dihydroxyflavone (DHF) as a small molecule agonist for tropomyosin-related kinase B (TrkB) facilitated understanding of the role of TrkB signaling in regulating higher brain functions. DHF can penetrate the blood-brain barrier after systemic administration and changes the performance of cognitive and emotional behavioral tasks. However, it is poorly understood how DHF modulates neuronal functions at cellular levels. Aiming to understand the cellular basis underlying DHF-induced modifications of the brain functions, we examined the effects of DHF on the hippocampal excitatory synaptic transmission.
Systemic administration of DHF can activate TrkB in the brain 4 and has been shown to modulate cognitive behavior: DHF can facilitate extinction of fear memory 5 and rescue learning and memory impairment in stressed animals, 6 aged rats, 7 mouse models of Alzheimer's disease, [8] [9] [10] [11] a rat model of schizophrenia, 12 and a mouse model of fragile X syndrome. 13 In addition, DHF has antidepressant-like effects in mice. [14] [15] [16] [17] These behavioral studies using DHF further support the importance of the TrkB signaling in regulating the higher brain functions and suggest a plausible therapeutic potential of DHF in various neuropsychiatric disorders. However, it has not been well characterized how DHF modulates physiological properties of brain neurons at the cellular or synaptic levels. Aiming to understand the cellular mechanism underlying the modification of the brain functions by DHF, in the present study, we examined the effect of DHF on the excitatory synaptic transmission using mouse hippocampal slices.
Our results show that DHF has a novel neuromodulatory effect that is hardly explained by activation of the TrkB receptor.
| ME TH ODS

| Animals
Male C57BL/6J mice were purchased from Japan SLC. Mice were 
| Electrophysiological analysis
Mice were decapitated under deep halothane anesthesia at the age of 9-11 weeks, and both hippocampi were isolated. Transverse hippocampal slices (380 μm) were cut using a tissue slicer and maintained in a humidified interface holding chamber at room temperature before use. Electrophysiological recordings were performed as described. 18, 19 Recordings were made in a submersiontype chamber maintained at 27.0-27.5°C and superfused at 2 mL/ min with saline composed of (in mmol/L): NaCl, 125; KCl, 2.5; NaH 2 PO 4 , 1.0; NaHCO 3 , 26.2; glucose, 11; CaCl 2 , 2.5; MgCl 2 , 1.3
(equilibrated with 95% O 2 /5% CO 2 ). In some experiments, the recording chamber was maintained at 37°C and superfused at 2.5 mL/min with the same saline. Excitatory postsynaptic potentials (EPSPs) arising from the mossy fiber (MF) synapses were evoked by stimulating the granule cell layer of the dentate gyrus (DG) and recorded from the stratum lucidum of the CA3 region using a glass pipette filled with 2 mol/L NaCl. The field EPSP amplitude was measured on analysis as described. 18 A criterion used to identify the MF input was more than 85% block of EPSP by an agonist of group II metabotropic glutamate receptors, (2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl)glycine (DCG-IV, 1 μmol/L). Single electrical stimulation was delivered at a frequency of 0.05 Hz unless otherwise specified. For recording field EPSP at CA3 to CA1 synapse, both stimulating and recording electrodes were placed in the stratum radiatum in the CA1 region. For recording field EPSPs at the medial perforant path (MPP)
to DG synapse, the stimulating and recording electrodes were placed in the middle third of the dentate molecular layer. The initial slope of field potentials was measured on analysis for CA3 to CA1 and MPP to DG synaptic responses. Triple-pulse stimulation at an interval of 200 ms was delivered at 0.033 Hz following an experimental protocol described previously. 18 All recordings were made using a Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA), filtered at 2 kHz, and stored in a personal computer via an interface (digitized at 10 kHz). DHF, K252a, and staurosporine were purchased from Wako Pure Chemical Industries, Ltd (Osaka, Japan).
ANA-12 was from Sigma-Aldrich. DCG-IV and 2-aminoethoxydiphenylborane (2-APB) were from Tocris Bioscience (Bristol, UK).
| Statistics
All data are presented as means ± SEM. Statistical tests are performed using GraphPad Prism version 7.01. Experiments with two groups were compared with unpaired two-tailed Student's t test unless otherwise specified in the figure legends, and experiments with more than two groups were subjected to one-way ANOVA, followed by the Tukey's test or Dunnett's test. Statistical significance was set at P < 0.05. The number of data "n" represents the number of slices.
| RESULTS
We first examined the effect of DHF at three major excitatory synapses in the hippocampus in adult mice. Bath-applied DHF Since BDNF plays a key role in the development of neuronal circuits, 1 we examined the effect of DHF at the immature MF synapse.
In 2-week-old juvenile mice, DHF had minimal effects on the MF synaptic transmission ( Figure 2D ). The magnitude of potentiation sharply increased thereafter and reached the mature level at the age of 4 weeks ( Figure 2D ,E). These results indicate that DHF preferentially potentiates synaptic transmission at the mature MF synapse.
Next, we examined the signaling mechanisms involved in the DHF-induced synaptic potentiation. We first tested the effect of tested more specific kinase inhibitors and modulators of intracellular Ca 2+ signaling and found that a relatively low concentration of 2-APB entirely suppressed the DHF-induced synaptic potentiation (see Table S1 for other drugs tested). Bath-applied 2-APB at 10 μmol/L had no effect on the basal synaptic transmission ( Figure 4A 
| DISCUSSION
In the present study, we have shown that the TrkB receptor agonist DHF preferentially potentiates hippocampal MF-CA3 synaptic transmission in a TrkB receptor-independent manner. In addition to the TrkB agonist action, DHF has been known to have TrkB-independent antioxidant activity. [24] [25] [26] While the robust synaptic potentiation observed here is unlikely to result from the antioxidant effect of DHF, these effects might share signaling pathways. Although the exact mechanism mediating the DHF-induced synaptic potentiation remains unknown, it was found to be sensitive to 2-APB below 10 μmol/L.
Such a low concentration of 2-APB can facilitate store-operated calcium entry, 27 activate TRPV3, 23 and block TRPM8 21 and TRPM2. 22 We have also found that the DHF-induced potentiation was suppressed to about 20% in magnitude by raising bath temperature from 27 to 37°C, suggesting that a putative DHF target molecule is thermosensitive. All of the above-mentioned TRP channels are thermosensitive, and TRPV3 could be a candidate target for DHF, because it can be activated in this temperature range. 28, 29 The rise in bath temperature might partially activate TRPV3, thereby augmenting the basal transmission efficacy and occluding the effect of DHF. However, 2-APB is an activator of TRPV3. Although 2-APB tended to augment synaptic transmission at 20 μmol/L, it had no effect on the basal transmission at 10 μmol/L. Therefore, the apparent block of the DHF effect by 2-APB cannot be simply explained by occlusion. Further studies with a more specific methodology would be required to reveal the signaling mechanism involved in the DHF-induced synaptic potentiation.
The synapse-selective effect of DHF might be ascribed to synapse-specific localization of DHF target molecules. However, it is unknown whether the above-mentioned putative targets are specifically expressed at the MF synapse. While TRPV3 is expressed in the hippocampus, 30 its synapse-specific localization has not been demonstrated. It should be noted that the MF synapse is characterized by prominent presynaptic facilitation and has a low probability of transmitter release. 31, 32 In general, at the synapse with the low release probability like the MF synapse, any presynaptic enhancing effect can be more manifest than the synapse with the high release probability. In addition, some neurotransmitter/receptor systems have specific modulatory effects on the MF synaptic transmission, as exemplified by kainate receptordependent synaptic enhancement. 33 DHF may indirectly induce synaptic potentiation by activating or augmenting such neurotransmitter/receptor systems.
In many behavioral studies, DHF has been used as a specific
TrkB receptor agonist and shown to modulate cognitive and emotional behavior. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Some of these behavioral changes were and TrkB-independent dual signaling pathways.
In conclusion, our present study demonstrates that DHF selectively potentiates hippocampal mossy fiber-CA3 excitatory synaptic transmission. The DHF-induced potentiation does not require TrkB receptor activation. This novel neuromodulatory effect of DHF should be taken into consideration in interpreting in vivo effects of DHF.
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